Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics

Area of Science:

• Cardiology
• Genetics
• Neuromuscular Disorders

Background:

• Duchenne muscular dystrophy (DMD) is an X-linked recessive genetic disorder.
• It results from the absence of the dystrophin protein, crucial for muscle cell membrane integrity.
• Cardiac complications, particularly heart failure, are a significant cause of morbidity and mortality in DMD patients.

Purpose of the Study:

• To review the underlying mechanisms (pathogenesis) of cardiac involvement in DMD.
• To discuss current and emerging therapeutic strategies for managing heart problems in DMD.

Main Methods:

• Literature review of scientific articles and clinical studies.
• Synthesis of information on DMD, dystrophin function, and cardiac pathophysiology.
• Analysis of therapeutic approaches for DMD-associated cardiomyopathy.

Main Results:

• The absence of dystrophin disrupts the sarcolemma, leading to progressive muscle degeneration, including cardiac muscle.
• DMD cardiomyopathy is characterized by fibrosis, inflammation, and eventual heart failure.
• Therapeutic strategies include supportive care, emerging gene therapies, and novel drug development.

Conclusions:

• Cardiac involvement is a critical and often fatal aspect of Duchenne muscular dystrophy.
• Understanding the pathogenesis is key to developing effective treatments.
• Multidisciplinary management and ongoing research are essential for improving outcomes in DMD patients.